Hultcrantz M, Kleinman D, Vij R, Escalante F, Delforge M, Kotowsky N, Bitetti J, Boytsov N, Camadoo-O’Byrne L, Happ LP, Germain G, Urosevic A, Mahendran M, Duh MS, Laliberte F, Cavo M, Lee HC. Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: a real-world observational study in the United States. haematol [Internet]. 2020Sep.10 [cited 2024Oct.21];. Available from: https://haematologica.org/article/view/haematol.2024.285893